5d 1m 3m 1y 5y 10y
There are no Transcripts on VCYT.
Veracyte Updates Presentation Date and Time at the Cowen and Company 34th Annual Health Care ConferencePR Newswire (Mon, 1:27PM)
PR Newswire (Feb 26, 2014)
PR Newswire (Feb 5, 2014)
PR Newswire (Dec 16, 2013)
VCYT vs. ETF Alternatives
Tuesday, Nov 262013, 12:48 PM
Tuesday, Nov 262013, 12:48 PM| 1 Comment
- Galena Biopharma (GALE +6.8%) initiated at Outperform at Oppenheimer. Price target is $6.
- Veracyte (VCYT +7%) started at Outperform at Leerink (PT $17), William Blair, and Cowen (PT $16).
- Surgical Care Affiliates (SCAI +2.8%) initiated at Buy at BofA. Price target is $34. Yesterday: Goldman starts SCAI at Neutral.
- Heartware (HTWR +2.3%) started at Buy at CRT Capital. Price target is $109.
- Mallinckrodt (MNK +2%) initiated at Buy at Jefferies. Price target is $60.
- Harvard Bioscience (HBIO +4.4%) upgraded to Buy from Neutral at Sidoti.
- Forest Labs (FRX +1.1%) upgraded to Neutral from Underweight at Piper. Price target hiked to $49 from $33.
- Cardiovascular Systems (CSII +0.9%) cut to Hold at Benchmark. Price target is $35.